RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Acasti Pharma Stock

Acasti Pharma Liabilities 2024

Acasti Pharma Liabilities

11.56 M USD

Ticker

ACST

ISIN

CA00430K8656

WKN

A3EP78

In 2024, Acasti Pharma's total liabilities amounted to 11.56 M USD, a -43.35% difference from the 20.4 M USD total liabilities in the previous year.

Acasti Pharma Aktienanalyse

What does Acasti Pharma do?

Acasti Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Acasti Pharma's Liabilities

Acasti Pharma's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Acasti Pharma's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Acasti Pharma's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Acasti Pharma's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Acasti Pharma’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Acasti Pharma stock

What is the level of liabilities of Acasti Pharma this year?

Acasti Pharma has a debt balance of 11.56 M USD this year.

What were the liabilities of Acasti Pharma compared to the previous year?

The liabilities of Acasti Pharma have increased by -43.35% dropped compared to the previous year.

What are the consequences of high debt for investors of Acasti Pharma?

High liabilities can pose a risk for investors of Acasti Pharma, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Acasti Pharma?

Low liabilities mean that Acasti Pharma has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Acasti Pharma affect the company?

An increase in liabilities of Acasti Pharma can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Acasti Pharma affect the company?

A decrease in the liabilities of Acasti Pharma can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Acasti Pharma?

Some factors that can influence the liabilities of Acasti Pharma include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Acasti Pharma so important for investors?

The liabilities of Acasti Pharma are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Acasti Pharma take to modify the liabilities?

To change its liabilities, Acasti Pharma can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Acasti Pharma pay?

Over the past 12 months, Acasti Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Acasti Pharma is expected to pay a dividend of 0 USD.

What is the dividend yield of Acasti Pharma?

The current dividend yield of Acasti Pharma is .

When does Acasti Pharma pay dividends?

Acasti Pharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Acasti Pharma?

Acasti Pharma paid dividends every year for the past 0 years.

What is the dividend of Acasti Pharma?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Acasti Pharma located?

Acasti Pharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Acasti Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Acasti Pharma from 11/8/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/8/2024.

When did Acasti Pharma pay the last dividend?

The last dividend was paid out on 11/8/2024.

What was the dividend of Acasti Pharma in the year 2023?

In the year 2023, Acasti Pharma distributed 0 USD as dividends.

In which currency does Acasti Pharma pay out the dividend?

The dividends of Acasti Pharma are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Acasti Pharma

Our stock analysis for Acasti Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Acasti Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.